Phase 1 18 trials
Phase 1
NCT07206225 Nov 2025 → Jan 2030 expected non-invasive bladder urothelial carcinoma Pfizer
Recruiting
No outcome recorded
Phase 1
NCT06870487 May 2025 → Apr 2026 classic Hodgkin lymphoma , diffuse large B-cell lymphoma , head and neck squamous cell carcinoma , melanoma +2 Pfizer
Terminated
No outcome recorded
Phase 1
NCT06974734 May 2025 → Mar 2026 head and neck squamous cell carcinoma , melanoma , non-small cell lung carcinoma , pancreatic ductal adenocarcinoma Pfizer
Terminated
No outcome recorded
Phase 1
NCT06704724 Dec 2024 → May 2026 colorectal neoplasm , non-small cell lung carcinoma , pancreatic ductal adenocarcinoma Pfizer
Terminated
No outcome recorded
Phase 1
NCT06580938 Nov 2024 → Jul 2025 colorectal cancer , head and neck cancer , melanoma , non-small cell lung carcinoma +2 Pfizer
Terminated
No outcome recorded
Phase 1
NCT06546553 Sep 2024 → Oct 2025 colorectal carcinoma , head and neck squamous cell carcinoma , non-small cell lung carcinoma , ovarian carcinoma +1 Pfizer
Terminated
No outcome recorded
Phase 1
NCT06447662 Jun 2024 → Oct 2026 expected colorectal neoplasm , non-small cell lung carcinoma , pancreatic ductal adenocarcinoma Pfizer
Active not recruiting
No outcome recorded
Phase 1
NCT06448364 May → Aug 2024 colorectal cancer , melanoma , non-small cell lung carcinoma , urothelial carcinoma Pfizer
Terminated
No outcome recorded
Phase 1
NCT06285097 Feb 2024 → Jan 2025 colorectal carcinoma , head and neck squamous cell carcinoma , melanoma , non-small cell lung carcinoma +3 Pfizer
Terminated
No outcome recorded
Phase 1
NCT05259397 Mar → Sep 2022 urinary bladder cancer Pfizer
Withdrawn
No outcome recorded
Phase 1
NCT05233436 Feb 2022 → Oct 2023 gastric cancer , gastroesophageal junction adenocarcinoma , head and neck squamous cell carcinoma , non-small cell lung carcinoma +1 Pfizer
Terminated
No outcome recorded
Phase 1
NCT05061537 Oct 2021 → Oct 2022 colorectal cancer , head and neck cancer , hepatocellular carcinoma , melanoma +6 Pfizer
Terminated
No outcome recorded
Phase 1
NCT04458259 Sep 2020 → Nov 2024 metastatic malignant neoplasm Pfizer
Terminated
No outcome recorded
Phase 1
NCT04254107 May 2020 → Dec 2023 cervical cancer , classic Hodgkin lymphoma , cutaneous melanoma , diffuse large B-cell lymphoma +8 Seagen Inc.
Terminated
No outcome recorded
Phase 1
NCT04171141 Nov 2019 → Nov 2023 colorectal adenocarcinoma , esophageal adenocarcinoma , gastric adenocarcinoma Pfizer
Terminated
No outcome recorded
Phase 1
NCT04152018 Nov 2019 → Dec 2024 bile duct cancer , endometrial cancer , esophageal cancer , gastric cancer +7 Pfizer
Terminated
No outcome recorded
Phase 1
NCT02573259 Feb 2016 → Nov 2020 head and neck squamous cell carcinoma , melanoma , non-small cell lung carcinoma , ovarian carcinoma +2 Pfizer
Completed
No outcome recorded
Phase 1
NCT02616185 Dec 2015 → Feb 2021 prostate neoplasm Pfizer
Terminated
No outcome recorded
Show 8 more trials Phase 1/2 3 trials
Phase 1/2
NCT05665361 Apr 2024 → Jun 2027 expected clear cell renal carcinoma , papillary renal cell carcinoma National Cancer Institute (NCI)
Recruiting
No outcome recorded
Phase 1/2
NCT04585815 Nov 2020 → May 2023 non-small cell lung carcinoma Pfizer
Terminated
No outcome recorded
Phase 1/2
NCT04181788 Mar 2020 → Mar 2022 non-small cell lung carcinoma Pfizer
Completed
No outcome recorded
Phase 2 3 trials
Phase 2
NCT07123090 Nov 2025 → Oct 2026 expected clear cell renal carcinoma Stephanie Berg
Recruiting
No outcome recorded
Phase 2
NCT06089265 Jun → Nov 2023 hereditary fructose intolerance Maastricht University Medical Center
Completed
No outcome recorded
Phase 2
NCT05241340 Feb 2022 → Aug 2025 overdue infiltrating bladder urothelial carcinoma The Methodist Hospital Research Institute
Active not recruiting
No outcome recorded
Phase 3 1 trial
Phase 3
NCT04165317 Dec 2019 → Dec 2024 overdue urinary bladder carcinoma Pfizer
Active not recruiting
No outcome recorded